Bridgewater Associates: Increased 7 Quarterly Healthcare Stock Positions

As the Dow Jones Industrial Average climbs 229 points and the S&P 500 climbs 23 points this morning, Wall St. Watchdog reveals information about the Bridgewater Associates’ top investments in the Healthcare sector:

  • Community Health Systems, Inc. (NYSE:CYH): On 3/31/11 Bridgewater Associates reported holding 257,210 shares with a market value of $10,285,828. This comprised 0.17% of the total portfolio. On 6/30/11, Bridgewater Associates held 958,497 shares with a market value of $24,614,203. This comprised 0.35% of the total portfolio. The net change in shares for this position over the two quarters is 701,287. About the company: Community Health Systems Inc. owns, leases, and operates hospitals in multiple states. The Hospitals services include emergency room services, general surgery, critical care, internal medicine, obstetrics and diagnostic services. Community Health also owns interests in physicians, physician practices, imaging centers, home health agencies and ambulatory surgery centers.
  • Johnson & Johnson (NYSE:JNJ): On 3/31/11 Bridgewater Associates reported holding 22,500 shares with a market value of $1,333,125. This comprised 0.02% of the total portfolio. On 6/30/11, Bridgewater Associates held 300,000 shares with a market value of $19,955,999. This comprised 0.28% of the total portfolio. The net change in shares for this position over the two quarters is 277,500. About the company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Merck & Co. Inc. (NYSE:MRK): On 3/31/11 Bridgewater Associates reported holding 240,900 shares with a market value of $7,952,109. This comprised 0.13% of the total portfolio. On 6/30/11, Bridgewater Associates held 492,300 shares with a market value of $17,373,267. This comprised 0.25% of the total portfolio. The net change in shares for this position over the two quarters is 251,400. About the company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.
  • Pfizer Inc. (NYSE:PFE): On 3/31/11 Bridgewater Associates reported holding 0,000 shares with a market value of $0. This comprised 0.00% of the total portfolio. On 6/30/11, Bridgewater Associates held 692,700 shares with a market value of $14,269,620. This comprised 0.20% of the total portfolio. The net change in shares for this position over the two quarters is 692,700. About the company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Thermo Fisher Scientific, Inc. (NYSE:TMO): On 3/31/11 Bridgewater Associates reported holding 174,208 shares with a market value of $9,677,254. This comprised 0.16% of the total portfolio. On 6/30/11, Bridgewater Associates held 199,942 shares with a market value of $12,874,265. This comprised 0.18% of the total portfolio. The net change in shares for this position over the two quarters is 25,734. About the company: Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.
  • Abbott Laboratories (NYSE:ABT): On 3/31/11 Bridgewater Associates reported holding 91,400 shares with a market value of $4,483,170. This comprised 0.08% of the total portfolio. On 6/30/11, Bridgewater Associates held 232,100 shares with a market value of $12,213,102. This comprised 0.17% of the total portfolio. The net change in shares for this position over the two quarters is 140,700. About the company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
  • Eli Lilly & Co. (NYSE:LLY): On 3/31/11 Bridgewater Associates reported holding 295,160 shares with a market value of $10,380,777. This comprised 0.17% of the total portfolio. On 6/30/11, Bridgewater Associates held 308,460 shares with a market value of $11,576,503. This comprised 0.16% of the total portfolio. The net change in shares for this position over the two quarters is 13,300. About the company: Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company’s products are sold in countries around the world. Eli Lilly’s products include neuroscience products, endocrine products, anti-infectives, cardiovascular agents, oncology products, and animal health products.

(Note: Data about Bridgewater Associates’ stock holdings are sourced from whalewisdom.com.  All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet